General Information of Drug Off-Target (DOT) (ID: OTUJZIDC)

DOT Name Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2)
Synonyms Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein
Gene Name ISLR2
Related Disease
Achalasia ( )
Congenital hydrocephalus ( )
Hydrocephalus ( )
UniProt ID
ISLR2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF13855
Sequence
MFPLRALWLVWALLGVAGSCPEPCACVDKYAHQFADCAYKELREVPEGLPANVTTLSLSA
NKITVLRRGAFADVTQVTSLWLAHNEVRTVEPGALAVLSQLKNLDLSHNFISSFPWSDLR
NLSALQLLKMNHNRLGSLPRDALGALPDLRSLRINNNRLRTLAPGTFDALSALSHLQLYH
NPFHCGCGLVWLQAWAASTRVSLPEPDSIACASPPALQGVPVYRLPALPCAPPSVHLSAE
PPLEAPGTPLRAGLAFVLHCIADGHPTPRLQWQLQIPGGTVVLEPPVLSGEDDGVGAEEG
EGEGDGDLLTQTQAQTPTPAPAWPAPPATPRFLALANGSLLVPLLSAKEAGVYTCRAHNE
LGANSTSIRVAVAATGPPKHAPGAGGEPDGQAPTSERKSTAKGRGNSVLPSKPEGKIKGQ
GLAKVSILGETETEPEEDTSEGEEAEDQILADPAEEQRCGNGDPSRYVSNHAFNQSAELK
PHVFELGVIALDVAEREARVQLTPLAARWGPGPGGAGGAPRPGRRPLRLLYLCPAGGGAA
VQWSRVEEGVNAYWFRGLRPGTNYSVCLALAGEACHVQVVFSTKKELPSLLVIVAVSVFL
LVLATVPLLGAACCHLLAKHPGKPYRLILRPQAPDPMEKRIAADFDPRASYLESEKSYPA
GGEAGGEEPEDVQGEGLDEDAEQGDPSGDLQREESLAACSLVESQSKANQEEFEAGSEYS
DRLPLGAEAVNIAQEINGNYRQTAG
Function Required for axon extension during neural development.

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Achalasia DISK845N Strong Genetic Variation [1]
Congenital hydrocephalus DIS7O6UL Strong Genetic Variation [2]
Hydrocephalus DISIZUF7 Strong Biomarker [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [4]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [5]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [6]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [7]
Triclosan DMZUR4N Approved Triclosan increases the expression of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [8]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN decreases the expression of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [10]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [9]
1,6-hexamethylene diisocyanate DMLB3RT Investigative 1,6-hexamethylene diisocyanate increases the methylation of Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2). [12]
------------------------------------------------------------------------------------

References

1 Innovative and Contemporary Interventional Therapies for Esophageal Diseases.J Thorac Imaging. 2019 Jul;34(4):217-235. doi: 10.1097/RTI.0000000000000423.
2 A novel ISLR2-linked autosomal recessive syndrome of congenital hydrocephalus, arthrogryposis and abdominal distension.Hum Genet. 2019 Jan;138(1):105-107. doi: 10.1007/s00439-018-1963-3. Epub 2018 Nov 27.
3 Essential Role of Linx/Islr2 in the Development of the Forebrain Anterior Commissure.Sci Rep. 2018 May 8;8(1):7292. doi: 10.1038/s41598-018-24064-0.
4 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
5 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
6 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
7 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
8 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
11 Transcriptomic?pathway?and?benchmark dose analysis of Bisphenol A, Bisphenol S, Bisphenol F, and 3,3',5,5'-Tetrabromobisphenol A in H9 human embryonic stem cells. Toxicol In Vitro. 2021 Apr;72:105097. doi: 10.1016/j.tiv.2021.105097. Epub 2021 Jan 18.
12 DNA methylation modifies urine biomarker levels in 1,6-hexamethylene diisocyanate exposed workers: a pilot study. Toxicol Lett. 2014 Dec 1;231(2):217-26. doi: 10.1016/j.toxlet.2014.10.024. Epub 2014 Oct 22.